Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 7, 2024. (Total: 234175Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Ovarian Neoplasms and NAT2[original query]
Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
Recent results in cancer research. Fortschritte der Krebsforschung. Progre?s dans les recherches sur le cancer 1998 154 47-85.
Hengstler J G, Arand M, Herrero M E, Oesch
Cancer and molecular biomarkers of phase 2.
Methods in enzymology 2006 1 400 618-27.
Dalhoff Kim, Buus Jensen Kaspar, Enghusen Poulsen Henr
Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Sep 17 (9): 2436-44.
Gates Margaret A, Tworoger Shelley S, Terry Kathryn L, Titus-Ernstoff Linda, Rosner Bernard, De Vivo Immaculata, Cramer Daniel W, Hankinson Susan
Association between genetic polymorphisms and ovarian cancer risk.
Anticancer research 0 28 (5B): 3079-81.
Delort Laetitia, Chalabi Nasséra, Satih Samir, Rabiau Nadège, Kwiatkowski Fabrice, Bignon Yves-Jean, Bernard-Gallon Dominique
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.
Cancer research 2009 Mar 69 (5): 1877-84.
Koutros Stella, Berndt Sonja I, Sinha Rashmi, Ma Xiaomei, Chatterjee Nilanjan, Alavanja Michael C R, Zheng Tongzhang, Huang Wen-Yi, Hayes Richard B, Cross Amanda
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
Molecular carcinogenesis 2011 May 50 (5): 397-402.
Goode Ellen L, White Kristin L, Vierkant Robert A, Phelan Catherine M, Cunningham Julie M, Schildkraut Joellen M, Berchuck Andrew, Larson Melissa C, Fridley Brooke L, Olson Janet E, Webb Penelope M, Chen Xiaoqing, Beesley Jonathan, Chenevix-Trench Georgia, Sellers Thomas A, ,
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.
Pharmacogenomics 2014 Feb 15 (3): 329-37.
Khrunin Andrey V, Khokhrin Denis V, Moisseev Alexey A, Gorbunova Vera A, Limborska Svetlana
TOP